PBI42 DISCONTINUATION PLAYS A ROLE WHEN EVALUATING THE COST EFFECTIVENESS OF THE SECOND BIOLOGICAL DRUG FOR PATIENTS WITH RHEUMATOID ARTHRITIS
May 1, 2020, 00:00
10.1016/j.jval.2020.04.105
https://www.valueinhealthjournal.com/article/S1098-3015(20)30293-X/fulltext
Title :
PBI42 DISCONTINUATION PLAYS A ROLE WHEN EVALUATING THE COST EFFECTIVENESS OF THE SECOND BIOLOGICAL DRUG FOR PATIENTS WITH RHEUMATOID ARTHRITIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30293-X&doi=10.1016/j.jval.2020.04.105
First page :
Section Title :
Open access? :
No
Section Order :
10563